Novartis Korea conducted 29 multinational clinical studies.

Published: 2005-06-14 06:59:00

Updated: 2005-06-14 06:59:00

About 29 multinational clinical studies were projected by Novartis Korea to conduct this year, which will be the top in number of the Koreas pharmaceutical industry, spending $30 million for 3 years financed by its head office, according to Novartis Koreaa announced on June 9.

29 studies included LTD600, once a day dosed drug for the treatment of B viral hepatitis, LAF237, a new type of anti...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.